Last updated on September 2016

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF


Brief description of study

This study is a randomized, double-blind, placebo-controlled trial in which eligible IPF subjects will be randomized to receive GBT440 or Placebo orally daily.

Clinical Study Identifier: NCT02846324

Find a site near you

Start Over

Tatiana Blue

New York, NY United States
  Connect »

Lisa Weaver

Salt Lake City, UT United States
  Connect »

Marla Watson

Kansas City, KS United States
  Connect »

Ashley Warden

Charleston, SC United States
  Connect »

Cori Fratelli

Denver, CO United States
  Connect »

Sharonda Keazor

Birmingham, AL United States
  Connect »

Edwinia Battle

Falls Church, VA United States
  Connect »

Francine McGonagle

Philadelphia, PA United States
  Connect »

Sandy Ditta

New Orleans, LA United States
  Connect »